Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$275K Buy
+3,925
New +$203K 0.01% 773
2026
Q1
Sell
-12,256
Closed -$361K 688
2025
Q4
$361K Buy
+12,256
New +$333K 0.02% 586

Other funds holding MRNA

IFG Advisory's MRNA Position: Q2 2026 in Review

IFG Advisory opened a new position in Moderna (MRNA) in Q2 2026: 3,925 shares worth $275K. The stake represents 0.01% of the portfolio and ranks #773 among its holdings. This is a return to the name: IFG Advisory previously reported a position in MRNA as recently as Q4 2025.

IFG Advisory first reported a position in MRNA in Q4 2025 and has held it in 2 quarters since. The position peaked at $361K in Q4 2025. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • IFG Advisory held 3,925 shares of Moderna worth $275K as of Q2 2026.
  • Moderna was a new IFG Advisory position in Q2 2026.
  • Moderna made up 0.01% of IFG Advisory's portfolio in Q2 2026, its #773 holding.
  • IFG Advisory first reported a position in Moderna in Q4 2025 and has held it in 2 quarters since.
  • IFG Advisory's Moderna position peaked at $361K in Q4 2025.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on IFG Advisory's 13F filing for Q2 2026, filed 14 Aug 2026.